Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Apr;32(4):678-690.
doi: 10.1002/oby.23988. Epub 2024 Mar 4.

Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesity

Talyia M Fordham  1 , Nazeen S Morelli  2 , Yesenia Garcia-Reyes  2 , Meredith A Ware  2 , Haseeb Rahat  2 , Divya Sundararajan  2 , Kelly N Z Fuller  2 , Cameron Severn  3 , Laura Pyle  3   4 , Craig R Malloy  5   6   7   8 , Eunsook S Jin  5   6 , Elizabeth J Parks  1 , Robert R Wolfe  9 , Melanie G Cree  2   10
Affiliations
Randomized Controlled Trial

Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesity

Talyia M Fordham et al. Obesity (Silver Spring). 2024 Apr.

Abstract

Objective: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, insulin resistance, and hepatic steatosis (HS). Because dietary essential amino acid (EAA) supplementation has been shown to decrease HS in various populations, this study's objective was to determine whether supplementation would decrease HS in PCOS.

Methods: A randomized, double-blind, crossover, placebo-controlled trial was conducted in 21 adolescents with PCOS (BMI 37.3 ± 6.5 kg/m2, age 15.6 ± 1.3 years). Liver fat, very low-density lipoprotein (VLDL) lipogenesis, and triacylglycerol (TG) metabolism were measured following each 28-day phase of placebo or EAA.

Results: Compared to placebo, EAA was associated with no difference in body weight (p = 0.673). Two markers of liver health improved: HS was lower (-0.8% absolute, -7.5% relative reduction, p = 0.013), as was plasma aspartate aminotransferase (AST) (-8%, p = 0.004). Plasma TG (-9%, p = 0.015) and VLDL-TG (-21%, p = 0.031) were reduced as well. VLDL-TG palmitate derived from lipogenesis was not different between the phases, nor was insulin sensitivity (p > 0.400 for both). Surprisingly, during the EAA phase, participants reported consuming fewer carbohydrates (p = 0.038) and total sugars (p = 0.046).

Conclusions: Similar to studies in older adults, short-term EAA supplementation in adolescents resulted in significantly lower liver fat, AST, and plasma lipids and thus may prove to be an effective treatment in this population. Additional research is needed to elucidate the mechanisms for these effects.

PubMed Disclaimer

References

REFERENCES

    1. Knochenhauer ES, Key TJ, Kahsar‐Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and White women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83(9):3078‐3082.
    1. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565‐4592.
    1. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β‐cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab. 2001;86(1):66‐71.
    1. Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR. Polycystic ovary syndrome is associated with tissue‐specific differences in insulin resistance. J Clin Endocrinol Metab. 2009;94(1):157‐163.
    1. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperaiidrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987;65(3):499‐507.

Publication types

LinkOut - more resources